Market Overview

Immunomedics Announces Results From Two Clinical Trials at Hematology Conference


Immunomedics, Inc. (Nasdaq: IMMU), today announced that two studies conducted by outside investigators that involved the Company's antibody drug candidates were presented at the 53^rd Annual Meeting of the American Society of Hematology.

Posted-In: News FDA


Related Articles (IMMU)

View Comments and Join the Discussion!